<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33454">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01898819</url>
  </required_header>
  <id_info>
    <org_study_id>4-2013-0195</org_study_id>
    <nct_id>NCT01898819</nct_id>
  </id_info>
  <brief_title>The Effect of Dexmedetomidine in Intraocular Pressure During Robot-Assisted Laparoscopic Radical Prostatectomy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intraocular pressure is significantly increase during robot-assisted laparoscopic radical
      prostatectomy which is performed in a steep trendelenburg position at prolonged timeds of
      pneumoperitoneum. Threrefore we decided to evaluate the effect of dexmedetomidine in
      intraocular pressure during roboti-assisted laparoscopic radical prostatectomy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Influence of dexmedetomidine in intraocular pressure during robot-assisted laparoscopic prostatectomy.</measure>
    <time_frame>change of intraocular pressure from T0 to T11 for 60mins</time_frame>
    <safety_issue>No</safety_issue>
    <description>T0: Pre-induciton T1: 5min after anesthesia induction T2: 5 min after establish pneumoperitoneum T3: 15min after steep trendelenburg position T4: 30min after steep trendelenburg position T5: 45min after steep trendelenburg T6: 60min after steep trendelenburg T7: 75min after steep trendelenburg T8: 5min after returning to horizontal position T9: operation end T10: 5min after tracheal extubation T11: 60min after tracheal extubation</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Steep Trendelenburg Position With Penumoperitoneum in Robot Assisted Laparoscopic Prostatectomy</condition>
  <arm_group>
    <arm_group_label>dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dexmedetomidine infusion from beginning of the anesthesia to just before returning to horizontal position</description>
  </arm_group>
  <arm_group>
    <arm_group_label>saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline infusion from same time period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <arm_group_label>dexmedetomidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline</intervention_name>
    <arm_group_label>saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. ASA class I-II

          2. obtaining written informed consent from the parents

          3. aged 20-70 years who were undergoing robot- assited laparoscopic prostatectomy

        Exclusion Criteria:

          1. eye surgery prevoiusly

          2. unstable angina or congestive heart failure

          3. concomittant eye disease (glaucoma, diabetic retinophaty, cataract, retinal
             detachment)

          4. high intraocular pressure over 30mmHg after screening test.

          5. uncontrolled hypertension (diastolic bp&gt;110mmHg)

          6. bradycardia under 60bpm

          7. Ventricular conduction abnormality

          8. hepatic failure

          9. renal failure

         10. drug hyperactivity

         11. neurological or psychiatric illnesses

         12. mental retardation

         13. patients who can`t read the consent form due to illiterate or foreigner
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 23, 2014</lastchanged_date>
  <firstreceived_date>July 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>DEXMEDETOMIDINE</keyword>
  <keyword>intraocular pressure</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
